Pertussis vaccination and whooping cough: And now what?

Expert Review of Vaccines

Volumn 13, Issue 10, 2014, Pages 1163-1165

  Guiso, Nicole ^a,b  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

Author keywords

Bordetella pertussis; diagnostics; pertussis vaccines; surveillance; whooping cough

Indexed keywords

PERTUSSIS VACCINE; ACELLULAR VACCINE;

BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; CELLULAR IMMUNITY; DEVELOPED COUNTRY; DISEASE TRANSMISSION; EVOLUTION; HUMAN; PERTUSSIS; POPULATION; REVIEW; TREATMENT DURATION; VACCINATION; VACCINE PRODUCTION; CHILD; IMMUNOLOGY; INFANT; PRESCHOOL CHILD; WHOOPING COUGH;

BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; PERTUSSIS VACCINE; VACCINES, ACELLULAR; WHOOPING COUGH;

EID: 84905982698     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2014.941816     Document Type: Review

References (21)

1. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005;18(2): 326-82
2. Zepp F, Heininger U, Mertsola J, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 2011;11(7):557-70
3. Grimprel E, Njamkepo E, Begue P, Guiso N. Rapid diagnosis of pertussis in young infants: comparison of culture, PCR, and infant's and mother's serology. Clin Diagn Lab Immunol 1997;4(6):723-6
4. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005; 24(5 Suppl):S58-61
5. Hegerle N, Guiso N. Epidemiology of whooping cough & typing of Bordetella pertussis. Future Microbiol 2013;8: 1391-403
6. Edwards KM, Decker MD. Pertussis vaccine. In: Plotkin S, Orenstein WA, Offit PA, editors. Vaccines. 4th edition. Saunders; Philadelphia, USA: 2008. p. 471-528
7. Njamkepo E, Cantinelli T, Guigon G, Guiso N. Genomic analysis and comparison of Bordetella pertussis isolates circulating in low and high vaccine coverage areas. Microbes infect 2008;10(14-15):1582-6
8. Bart MJ, Harris SR, Advani A, et al. Global population structure and evolution of bordetella pertussis and their relationship with vaccination. mBio 2014;5(2):e01074
9. Hegerle N, Paris AS, Brun D, et al. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin. Clin Microbiol Infect 2012;18(9):E340-6
10. Bordet J, Sleeswijk JG. Sérodiagnostic et variabilité des microbes suivant le milieu de culture. Ann Inst Pasteur (Paris) 1910; 24(6):476-94
11. Higgs R, Higgins SC, Ross PJ, Mills KH. Immunity to the respiratory pathogen Bordetella pertussis. Mucosal Immunol 2012;5(5):485-500
12. Clark TA. Changing pertussis epidemiology: everything old is new again. J Infect Dis 2014;209(7):978-81
13. Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci USA 2014;111(2): 787-92
14. Carlsson RM, Trollfors B. Control of pertussis - lessons learnt from a 10-year surveillance programme in Sweden. Vaccine 2009;27(42):5709-18
15. Barkoff AM, Mertsola J, Guillot S, et al. Appearance of Bordetella pertussis strains not expressing vaccine antigen pertactin in Finland. Clin Vaccine Immunol 2012; 19(10):1703-4
16. Lam C, Octavia S, Ricafort L, et al. Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia. Emerg Infect Dis 2014;20(4):626-33
17. Miyaji Y, Otsuka N, Toyoizumi-Ajisaka H, et al. Genetic analysis of. Bordetella pertussis isolates from the 2008-2010 pertussis epidemic in Japan. PLoS One 2013;8(10):e77165
18. Pawloski LC, Queenan AM, Cassiday PK, et al. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the US. Clin Vaccine Immunol 2014;21(2):119-25
19. Queenan AM, Cassiday PK, Evangelista A. Pertactin-negative variants of Bordetella pertussis in the United States. N Engl J Med 2013;368(6):583-4
20. Quinlan T, Musser KA, Currenti SA, et al. Pertactin-negative variants of Bordetella pertussis in New York State: a retrospective analysis. 2004Mol Cell Probes 2014;28(4): 138-40
21. Cherry JD, Tan T, Wirsing von Konig CH, et al. Clinical definitions of pertussis: summary of a Global Pertussis Initiative roundtable meeting, February 2011. Clin Infect Dis 2012;54(12):1756-64